Contents

Search


cachexia

Also see: cachexia-anorexia syndrome. Clinical manifestations: 1) progressive weight loss 2) lipolysis 3) loss of visceral & skeletal protein mass Management: - artificial nutrition does not improve morbidity or mortality [2] - olanzapine may improve appetite, weight & quality of life in patients with metastatic cancer [3] - small meals of foods preferred by elderly at the end of life [4]

Specific

anorexia-cachexia syndrome cachexia-anorexia syndrome

General

unintentional weight loss

References

  1. Bruera E, Neumann CM. Management of specific symptom complexes in patients receiving palliative care. CMAJ. 1998 Jun 30;158(13):1717-26. Review. PMID: 9676549 PMCID: PMC1229444 Free PMC article
  2. Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  3. Sandhya L et al. Randomized double-blind placebo-controlled study of olanzapine for chemotherapy- related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer. J Clin Oncol 2023 May 10; 41:2617 PMID: 36977285 Clinical Trial. https://ascopubs.org/doi/10.1200/JCO.22.01997 - Roeland EJ, Bohlke K, Baracos VE et al Cancer Cachexia: ASCO Guideline Rapid Recommendation Update. J Clin Oncol. 2023 Sep 1;41(25):4178-4179. PMID: 37467399
  4. Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022